Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Radiochemotherapy with Docetaxel and Oxaliplatin in GEJ Adenocarcinoma
NCT00374985Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Oct 2005
- Primary completion
- Sep 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin in adenocarcinoma of the gastroesophageal junction, sponsored by Johannes Gutenberg University Mainz. Started Oct 2005; status: completed.
02
Drugs
docetaxeloxaliplatin
03
Conditions
adenocarcinoma of the gastroesophageal junction
Beyond the preview
Go deeper on NCT00374985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374985.